ARTICLE | Financial News
BioChem Pharma beats Street EPS
July 26, 2000 7:00 AM UTC
BioChem (BCHE; TSE:BCH) reported second quarter EPS of US$0.26, beating the consensus estimate by a penny. BCHE reported C$47.8 million in royalties on Epivir lamivudine 3TC to treat HIV and Zeffix la...